Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page's metadata/content.
    Difference
    0.0%
    Check dated 2026-06-05T21:43:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The revision indicator updated from v3.5.3 to v3.5.4, signaling a new page release. This reflects an internal update to the page rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-05-15T15:35:00.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3 in the site footer, reflecting a minor ClinicalTrials.gov software/content-display update rather than any change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2. No visible changes to the study record content are indicated.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions described on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision labels updated from v3.4.3 to v3.5.0. No visible changes to study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:54.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.